Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference By: Abiomed, Inc. via Business Wire May 31, 2022 at 07:00 AM EDT Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com. FORWARD-LOOKING STATEMENTS Any forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005131/en/Contacts Investor: Todd Trapp Vice President and Chief Financial Officer +1 (978) 646-1680 ttrapp@abiomed.com Media: Jenny Leary Associate Director, U.S. Communications +1 (978) 882-8491 jleary@abiomed.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference By: Abiomed, Inc. via Business Wire May 31, 2022 at 07:00 AM EDT Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com. FORWARD-LOOKING STATEMENTS Any forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005131/en/Contacts Investor: Todd Trapp Vice President and Chief Financial Officer +1 (978) 646-1680 ttrapp@abiomed.com Media: Jenny Leary Associate Director, U.S. Communications +1 (978) 882-8491 jleary@abiomed.com
Abiomed, Inc. (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022 at 2:00pm CT. ABOUT ABIOMED Based in Danvers, Massachusetts, USA, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com. FORWARD-LOOKING STATEMENTS Any forward-looking statements are subject to risks and uncertainties such as those described in Abiomed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. View source version on businesswire.com: https://www.businesswire.com/news/home/20220531005131/en/
Investor: Todd Trapp Vice President and Chief Financial Officer +1 (978) 646-1680 ttrapp@abiomed.com Media: Jenny Leary Associate Director, U.S. Communications +1 (978) 882-8491 jleary@abiomed.com